Cilostamide

CAS No. 68550-75-4

Cilostamide( OPC3689 )

Catalog No. M20984 CAS No. 68550-75-4

Cilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 59 In Stock
2MG 33 In Stock
5MG 53 In Stock
10MG 86 In Stock
25MG 174 In Stock
50MG 258 In Stock
100MG 387 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cilostamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Cilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
  • Description
    Cilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    OPC3689
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    68550-75-4
  • Formula Weight
    342.43
  • Molecular Formula
    C20H26N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:31 mg/mL (90.53 mM)
  • SMILES
    CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1
  • Chemical Name
    N-Cyclohexyl-N-methyl-4-(12-dihydro-2-oxo-6-quinolyloxy)butyramide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cilostamide affects in a concentration and exposure time-dependent manner the viability and the kinetics of in vitro maturation of caprine and bovine oocytes.[J]. Research in veterinary science 2018.
molnova catalog
related products
  • Gisadenafil

    Gisadenafil is a selective inhibitor of phosphodiesterase 5 (PDE5) with an IC50 of 3.6 nM and prevents degradation of cGMP.

  • BRL 50481

    BRL-50481 is a novel and selective inhibitor of PDE7 with IC50s of 0.15 12.1 62 and 490 μM for PDE7A PDE7B PDE4 and PDE3 respectively.

  • AWD 12-281

    AWD 12-281 is a selective phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory and bronchodilator activity used in the study of chronic obstructive pulmonary disease (COPD).